Who We Are
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!
HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States
HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty gHealth Insurers Must Cover All PreP
The three FDA-approved versions are included.Glassman: How Trump can meet his goal of ending AIDS
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States within 10 years” by launching the federal Ending the HIV Epidemic I...Long Covid, AI ‘obsession,’ trust: What STAT readers thought went overlooked in 2024
Long Covid, AI, and trust: STAT readers on what went underdiscussed in 2024 — and what they think will happen in 2025.